Eli Lilly and Company

LillyLilly is a global healthcare leader that unites caring with discovery to make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism.

www.lilly.com

Eli Lilly and Company RSS Channel

Display # 
Title Published Date
Lilly Diabetes launches new Disney book for families affected by type 1 diabetes 24 September 2015
Results from the largest known cholesterol survey conducted in the U.S. 05 November 2012
Boehringer Ingelheim and Lilly introduce the My Well Planner lifestyle improvement program 13 September 2012
Lilly Diabetes launches mobile application for whose who support people with type 1 diabetes 04 September 2012
Lilly reports second-quarter 2012 results 25 July 2012
Lilly expands strategic partnership with Chinese manufacturer Novast 12 June 2012
Lilly Introduces Global 'Innovation Starts Here' Initiative to Foster Innovation and Quality Science 04 March 2012
Lilly releases its most comprehensive corporate responsibility report 14 February 2012
Fifth Lilly Oncology on Canvas Art Competition invites all touched by cancer 09 February 2012
Most couples prefer spontaneity in the bedroom 11 December 2011
Understand Barriers to Progression of Insulin Treatment 01 December 2011
Lilly Provides Additional Funding to Infectious Disease Research Institute to Identify New Tuberculosis Therapies 24 November 2011
Lilly CEO Says Appropriate Assessment of Both Benefits and Risks Critical in Regulatory Process 02 November 2011
Lilly Reports Third-Quarter 2011 Results 21 October 2011
New Study Shows Cialis® Significantly Improved Study Endpoints 12 October 2011
Lilly Launches Open Innovation Drug Discovery Platform 29 September 2011
Lilly Invests $30 Million in Partnership to Address Non-Communicable Diseases 15 September 2011
Linagliptin Receives Approval in Europe for the Treatment of Type 2 Diabetes 26 August 2011
Lilly Announces Review of Data on Long-Term Raloxifene Treatment 10 August 2011
Lilly Global Giving Puts Power of Philanthropy in Employees' Hands 27 July 2011

Most Popular Now

New antibiotic Zavicefta approved i…

AstraZeneca today announced that the European Commission (EC) has granted marketing authorisation for Zavicefta (ceftazidime-avibactam, previously known as CAZ AVI), a ne...

Read more

Novo Nordisk and Aarhus University …

Novo Nordisk and Aarhus University's Science and Technology faculty today signed a collaboration agreement to strengthen protein technology research and development. Unde...

Read more

AstraZeneca enters licensing agreem…

AstraZeneca today announced that it has entered into agreements that support its strategic focus on three main therapy areas; Respiratory, Inflammation and Autoimmunity, ...

Read more

Novartis adds bispecific antibodies…

Today Novartis announced that it has entered into a collaboration and licensing agreement with Xencor for the development of bispecific antibodies for treating cancer. Th...

Read more

Bristol-Myers Squibb and PsiOxus Th…

Bristol-Myers Squibb Company (NYSE: BMY) and PsiOxus Therapeutics, Ltd. (PsiOxus) today announced an exclusive clinical collaboration agreement to evaluate the safety, to...

Read more

Bristol-Myers Squibb acquires Cormo…

Bristol-Myers Squibb Company (NYSE:BMY) and Cormorant Pharmaceuticals announced today that Bristol-Myers Squibb has acquired all of the outstanding capital stock of Cormo...

Read more

Sanofi Pasteur signs research agree…

Sanofi and its vaccines global business unit Sanofi Pasteur announced today a Cooperative Research and Development Agreement with the Walter Reed Army Institute of Resear...

Read more

FDA advances Precision Medicine Ini…

In support of the President’s Precision Medicine Initiative, the U.S. Food and Drug Administration has issued two draft guidances that, when finalized, will provide a fle...

Read more

Merck and Pfizer initiate Phase III…

Merck KGaA, Darmstadt, Germany, and Pfizer (NYSE: PFE) have announced the initiation of a Phase III study, JAVELIN Ovarian 100, to evaluate the efficacy and safety of ave...

Read more

Merck commits €1.5 million to the G…

Merck, a leading science and technology company, today announced it would continue to support the advancement of medical science in the field of fertility through the Gra...

Read more

Twisting and turning to target anti…

Researchers are getting closer to understanding how some natural antibiotics work so they can develop drugs that mimic them. A recent review commissioned by the British g...

Read more

A 'big data' approach to developing…

Scientists are starting to accumulate huge datasets on which genes mutate during cancer, allowing for a more systematic approach to "precision medicine." In a study publi...

Read more

Digest World Pharma Newsletter

Subscribe to our weekly Digest World Pharma Newsletter and stay updated on the latest World Pharma News. Subscribe now, it's free!

Pharmaceutical Companies

[ A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Z ]

© World Pharma News 2006 - 2016